| manager |
|
| language |
- |
| license |
- |
| created at |
2021-05-11 01:03:40 UTC |
| updated at |
2021-05-11 05:08:34 UTC |
|
Just test
|
596 entries
|
There is 0 pattern entry.
|
mechanical ventilation
|
Therapy |
|
|
methylprednisolone and low molecular weight heparin
|
Therapy |
|
|
methylprednisolone and unfractionated heparin
|
Therapy |
|
|
movement restriction
|
Therapy |
|
|
non-invasive mechanical ventilation
|
Therapy |
|
|
not receive any treatment
|
Therapy |
|
|
Prevention of or induction of TxA2
|
Therapy |
|
|
Recombinant ACE2
|
Therapy |
|
|
sarilumab + methylprednisolone plus SOC for COVID-19
|
Therapy |
|
|
sarilumab plus SOC
|
Therapy |
|
|
social distancing
|
Therapy |
|
|
surgical intervention
|
Therapy |
|
|
target RAS using specific candidate chemotherapeutic drugs
|
Therapy |
|
|
transfusion of 2 or more units of packed red blood cells in a day
|
Therapy |
|
|
with corticosteroids
|
Therapy |
|